Opexa Therapeutics, Inc. 4
4 · Opexa Therapeutics, Inc. · Filed Aug 9, 2013
Insider Transaction Report
Form 4
Radhakrishnan Karthik
Chief Financial Officer
Transactions
- Purchase
Common Stock
2013-08-08$1.50/sh+50,000$75,000→ 50,000 total
Footnotes (1)
- [F1]Purchased in an underwritten public offering which is expected to close on August 13, 2013.